Indeed, NSCLC cells harboring T790M mutant EGFR show more than a 1000-fold resistance to first-generation EGFR TKIs as compared with parental cells, even if they have EGFR-activating mutations [90]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.